Annual Drug Patent Expirations for PROCYSBI
Procysbi is a drug marketed by Horizon and is included in two NDAs. There are twelve patents protecting this drug.
Drug patent litigation for PROCYSBI.
This drug has eighteen patent family members in eighteen countries.
The generic ingredient in PROCYSBI is cysteamine bitartrate. Additional details are available on the cysteamine bitartrate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com